| scholarly article | Q13442814 |
| P50 | author | William R. Markesbery | Q56850445 |
| Erin L Abner | Q60665975 | ||
| Frederick A. Schmitt | Q64778804 | ||
| Peter T Nelson | Q90936675 | ||
| Gregory A Jicha | Q92594727 | ||
| P2093 | author name string | Marta S Mendiondo | |
| Daron G Davis | |||
| Huaichen Liu | |||
| P2860 | cites work | The importance of neuritic plaques and tangles to the development and evolution of AD | Q22241659 |
| The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 | ||
| Neuropathologic features of amnestic mild cognitive impairment | Q28238965 | ||
| A specific amyloid-beta protein assembly in the brain impairs memory | Q28854597 | ||
| Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease | Q29617286 | ||
| Is amyloid beta-peptide neurotoxic or neuroprotective and what is its role in the binding of metal ions? | Q30310306 | ||
| Neuropathology lessons in vascular dementia | Q30984777 | ||
| Density profiles of Alzheimer disease regional brain pathology for the huddinge brain bank: pattern recognition emulates and expands upon Braak staging | Q33444320 | ||
| Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration | Q33685317 | ||
| An alternative interpretation of the amyloid Abeta hypothesis with regard to the pathogenesis of Alzheimer's disease | Q33879010 | ||
| Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants | Q34164504 | ||
| Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment | Q34198357 | ||
| Neuropathology of Alzheimer's disease and other dementias | Q34262766 | ||
| Staging of Alzheimer-related cortical destruction | Q34349510 | ||
| The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease | Q34992780 | ||
| Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease. | Q35019451 | ||
| Cognitive impact of subcortical vascular and Alzheimer's disease pathology | Q35750397 | ||
| A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide--the first step of a fatal cascade | Q35918740 | ||
| Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective? | Q36135513 | ||
| AD brain pathology: vascular origins? Results from the HAAS autopsy study | Q36219411 | ||
| Advances in vascular cognitive impairment 2005. | Q36367312 | ||
| Neuropathology of Alzheimer disease: pathognomonic but not pathogenic | Q36485646 | ||
| Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal. | Q36568099 | ||
| Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience | Q36621520 | ||
| Morphological substrates of cognitive decline in nonagenarians and centenarians: a new paradigm? | Q36736545 | ||
| Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons | Q38397294 | ||
| Neuropathology of older persons without cognitive impairment from two community-based studies | Q38405842 | ||
| Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of very old patients | Q40377763 | ||
| Staging of Alzheimer's disease-related neurofibrillary changes | Q40416705 | ||
| Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease | Q40573179 | ||
| Diagnosis and staging of Alzheimer disease | Q41612700 | ||
| Neuropathologic diagnosis of Alzheimer disease: consensus between practicing neuropathologists? | Q41686190 | ||
| Brain infarction and the clinical expression of Alzheimer disease. The Nun Study | Q42435324 | ||
| Shared random effects analysis of multi-state Markov models: application to a longitudinal study of transitions to dementia. | Q42675504 | ||
| Modelling mini mental state examination changes in Alzheimer's disease | Q43674870 | ||
| Alzheimer disease without neocortical neurofibrillary tangles: "a second look". | Q44840307 | ||
| Neuropathological background of twenty-seven centenarian brains | Q44991568 | ||
| Risk factors for transitions from normal to mild cognitive impairment and dementia. | Q45065475 | ||
| The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease | Q46155290 | ||
| A neuropathological subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change | Q46788045 | ||
| Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease | Q46886267 | ||
| The validity and reliability of 6 sets of clinical criteria to classify Alzheimer's disease and vascular dementia in cases confirmed post-mortem: added value of a decision tree approach | Q46900237 | ||
| Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease | Q47918430 | ||
| Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function | Q47945508 | ||
| Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: a study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) | Q48126915 | ||
| Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease | Q48186602 | ||
| Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology. | Q48270554 | ||
| Quantitative immunohistochemical analysis of the distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of nonagenarians and centenarians | Q48374067 | ||
| Lewy body pathology in late-onset familial Alzheimer's disease: a clinicopathological case series. | Q48445249 | ||
| The neuropathology of alcohol-specific brain damage, or does alcohol damage the brain? | Q48463834 | ||
| Argyrophilic grain disease in demented subjects presenting initially with amnestic mild cognitive impairment | Q48493664 | ||
| Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype | Q48499517 | ||
| Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia | Q48550309 | ||
| Deposition of amyloid beta protein in non-Alzheimer dementias: evidence for a neuronal origin of parenchymal deposits of beta protein in neurodegenerative disease. | Q48565165 | ||
| Consensus neuropathological diagnosis of common dementia syndromes: testing and standardising the use of multiple diagnostic criteria. | Q48575720 | ||
| Comparison of neuropathologic criteria for the diagnosis of Alzheimer's disease | Q48662441 | ||
| The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary | Q48662464 | ||
| Alpha-Synuclein aggregation in pathological aging and Alzheimer's disease: the impact of beta-amyloid plaque level | Q48704701 | ||
| Alpha-synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation | Q49097736 | ||
| Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. | Q50742360 | ||
| Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. | Q50758048 | ||
| The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. | Q51183354 | ||
| Correlation between scores for dementia and counts of 'senile plaques' in cerebral grey matter of elderly subjects. | Q51241982 | ||
| Coexisting cerebral infarction in Alzheimer's disease is associated with fast dementia progression: applying the National Institute for Neurological Disorders and Stroke/Association Internationale pour la Recherche et l'Enseignement en Neurosciences | Q51903055 | ||
| Diabetes mellitus increases adverse neurocognitive outcome after coronary artery bypass grafting surgery. | Q51913813 | ||
| Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study. | Q51923948 | ||
| AD lesions and infarcts in demented and non-demented Japanese-American men. | Q51935333 | ||
| "Preclinical" AD revisited: neuropathology of cognitively normal older adults. | Q51975129 | ||
| Neuropathologic substrate of mild cognitive impairment. | Q51985667 | ||
| Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia. | Q52011170 | ||
| Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study. | Q52030230 | ||
| Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients. | Q52031965 | ||
| The effects of additional pathology on the cognitive deficit in Alzheimer disease. | Q52044217 | ||
| Memory and mental status correlates of modified Braak staging. | Q52170951 | ||
| A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. | Q53191092 | ||
| Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. | Q53243175 | ||
| Neuropathologic criteria for diagnosing Alzheimer disease in persons with pure dementia of Alzheimer type. | Q53265445 | ||
| Cognitive impact of neuronal pathology in the entorhinal cortex and CA1 field in Alzheimer's disease. | Q53274954 | ||
| Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. | Q53312706 | ||
| Amyloid-beta in Alzheimer Disease: The Null versus the Alternate Hypotheses | Q57341546 | ||
| Neuropathological findings in the very old. Results from the first 101 brains of a population-based longitudinal study of dementing disorders | Q73808495 | ||
| Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease | Q77614817 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| autopsy | Q41482 | ||
| P304 | page(s) | 1136-1146 | |
| P577 | publication date | 2007-12-01 | |
| P1433 | published in | Journal of Neuropathology & Experimental Neurology | Q15716771 |
| P1476 | title | Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity | |
| P478 | volume | 66 |
| Q35208143 | "End-stage" neurofibrillary tangle pathology in preclinical Alzheimer's disease: fact or fiction? |
| Q38841003 | "New Old Pathologies": AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS). |
| Q37530219 | 5-Hydroxymethylation-associated epigenetic modifiers of Alzheimer's disease modulate Tau-induced neurotoxicity |
| Q39143773 | A Customized Quantitative PCR MicroRNA Panel Provides a Technically Robust Context for Studying Neurodegenerative Disease Biomarkers and Indicates a High Correlation Between Cerebrospinal Fluid and Choroid Plexus MicroRNA Expression. |
| Q37331417 | A fibril-specific, conformation-dependent antibody recognizes a subset of Abeta plaques in Alzheimer disease, Down syndrome and Tg2576 transgenic mouse brain |
| Q90140035 | A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia |
| Q37122270 | A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. |
| Q37024041 | APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature |
| Q37194280 | Acetylcholinesterase inhibitor treatment is associated with relatively slow cognitive decline in patients with Alzheimer's disease and AD + DLB |
| Q31033082 | Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia |
| Q36692073 | Altered Proteins in the Aging Brain |
| Q22251261 | Alzheimer's disease as homeostatic responses to age-related myelin breakdown |
| Q33736582 | Alzheimer's disease biomarker discovery in symptomatic and asymptomatic patients: experimental approaches and future clinical applications |
| Q35231770 | Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies |
| Q35687044 | Alzheimer's disease: pathological mechanisms and recent insights |
| Q33730222 | Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment |
| Q42641035 | Amyloid Plaque-Associated Oxidative Degradation of Uniformly Radiolabeled Arachidonic Acid |
| Q50860519 | Amyloid-β may be released from non-junctional varicosities of axons generated from abnormal tau-containing brainstem nuclei in sporadic Alzheimer's disease: a hypothesis. |
| Q55146345 | An Algorithm for Preclinical Diagnosis of Alzheimer's Disease. |
| Q33750657 | Applicability of digital analysis and imaging technology in neuropathology assessment |
| Q37477335 | Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing |
| Q34581052 | Association between male gender and cortical Lewy body pathology in large autopsy series |
| Q38684307 | Brain microvascular injury and white matter disease provoked by diabetes-associated hyperamylinemia |
| Q36395714 | Brain pathologies in extreme old age. |
| Q36589156 | Brain-derived neurotrophic factor and TrkB expression in the "oldest-old," the 90+ Study: correlation with cognitive status and levels of soluble amyloid-beta |
| Q30378181 | Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease. |
| Q40741759 | Calcineurin proteolysis in astrocytes: Implications for impaired synaptic function |
| Q42136210 | Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease? |
| Q42319729 | Cerebrovascular pathology and Alzheimer's disease |
| Q38236878 | Challenges of multimorbidity of the aging brain: a critical update |
| Q36627110 | Clinical-pathologic correlations in vascular cognitive impairment and dementia |
| Q37434914 | Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling. |
| Q37027165 | Comparison of symptomatic and asymptomatic persons with Alzheimer disease neuropathology |
| Q24599735 | Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease |
| Q37380546 | Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre |
| Q36575903 | Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature |
| Q57724897 | Dementia in the oldest old |
| Q47351811 | Detergent Insoluble Proteins and Inclusion Body-Like Structures Immunoreactive for PRKDC/DNA-PK/DNA-PKcs, FTL, NNT, and AIFM1 in the Amygdala of Cognitively Impaired Elderly Persons. |
| Q90442086 | Diffuse Amyloid-β Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons' Brains Lacking Neuritic Amyloid Plaques |
| Q36438010 | Digital pathology and image analysis for robust high-throughput quantitative assessment of Alzheimer disease neuropathologic changes |
| Q47435877 | Early Alzheimer-type lesions in cognitively normal subjects |
| Q31028501 | Epigenetic silencing of nucleolar rRNA genes in Alzheimer's disease |
| Q33513475 | Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individuals |
| Q39213503 | Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging |
| Q90707233 | Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948 |
| Q37228239 | Hippocampal Sclerosis but Not Normal Aging or Alzheimer Disease Is Associated With TDP-43 Pathology in the Basal Forebrain of Aged Persons |
| Q28083841 | Hippocampal Sclerosis of Aging Can Be Segmental: Two Cases and Review of the Literature |
| Q34992164 | Hippocampal sclerosis in advanced age: clinical and pathological features. |
| Q26996741 | Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease |
| Q33710643 | Human cerebral neuropathology of Type 2 diabetes mellitus |
| Q33640390 | Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency |
| Q33668661 | Hyperphosphorylated tau is elevated in Alzheimer's disease with psychosis |
| Q34783722 | Immunotherapy for Alzheimer's disease |
| Q48943323 | In vivo imaging of astrocytosis in Alzheimer's disease: an ¹¹C-L-deuteriodeprenyl and PIB PET study |
| Q64054840 | Interpretable classification of Alzheimer’s disease pathologies with a convolutional neural network pipeline |
| Q38113683 | Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid |
| Q34504659 | Is synaptic loss a unique hallmark of Alzheimer's disease? |
| Q34776816 | Is there a neuropathology difference between mild cognitive impairment and dementia? |
| Q57112716 | Isolation of Cerebral Capillaries from Fresh Human Brain Tissue |
| Q33729642 | Low sensitivity in clinical diagnoses of dementia with Lewy bodies |
| Q34021015 | MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study |
| Q47214829 | MicroRNA expression patterns in human anterior cingulate and motor cortex: A study of dementia with Lewy bodies cases and controls. |
| Q33701433 | MicroRNA in Situ Hybridization in the Human Entorhinal and Transentorhinal Cortex |
| Q34284143 | MicroRNA-153 physiologically inhibits expression of amyloid-β precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients |
| Q37069478 | MicroRNAs (miRNAs) in neurodegenerative diseases |
| Q34247588 | Mild cognitive impairment: statistical models of transition using longitudinal clinical data |
| Q35197386 | Missense variants in CFTR nucleotide-binding domains predict quantitative phenotypes associated with cystic fibrosis disease severity |
| Q33828911 | Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons |
| Q37954450 | Modeling the dementia epidemic. |
| Q38836004 | Molecular and cellular pathophysiology of preclinical Alzheimer's disease |
| Q33453702 | Multiprotein deposits in neurodegenerative disorders: our experience in the tissue brain bank of Navarra |
| Q39151408 | Multiregional analysis of global 5-methylcytosine and 5-hydroxymethylcytosine throughout the progression of Alzheimer's disease |
| Q52589491 | NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. |
| Q34635272 | National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease |
| Q37677417 | Neocortical β-amyloid area is associated with dementia and APOE in the oldest-old |
| Q38388660 | Neuritic and Diffuse Plaque Associations with Memory in Non-Cognitively Impaired Elderly |
| Q37701241 | Neurodegeneration-associated instability of ribosomal DNA. |
| Q40709414 | Neurodegenerative changes in the brainstem and olfactory bulb in people older than 50 years old: a descriptive study |
| Q36629135 | Neuroinflammatory phenotype in early Alzheimer's disease |
| Q35529951 | Neuropathologic features associated with Alzheimer disease diagnosis: age matters |
| Q33683377 | Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates |
| Q43656306 | Neuropathological and transcriptomic characteristics of the aged brain. |
| Q36755159 | Neuropathological approaches to cerebral aging and neuroplasticity |
| Q36325404 | Neuropathological diagnoses and clinical correlates in older adults in Brazil: A cross-sectional study. |
| Q92303551 | Neuropathological lesions in the very old: results from a large Brazilian autopsy study |
| Q37218110 | Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship |
| Q47896160 | Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series |
| Q60699181 | Non-Alzheimer’s contributions to dementia and cognitive resilience in The 90+ Study |
| Q41763844 | Non-random distribution of methyl-CpG sites and non-CpG methylation in the human rDNA promoter identified by next generation bisulfite sequencing |
| Q38915426 | Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi |
| Q36130996 | Overview and findings from the religious orders study |
| Q36226167 | Overview and findings from the rush Memory and Aging Project |
| Q34268519 | Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: Implications for Aβ accumulation in AD brain |
| Q33875127 | P-gp Protein Expression and Transport Activity in Rodent Seizure Models and Human Epilepsy |
| Q57174485 | Pathologies Underlying Longitudinal Cognitive Decline in the Oldest Old |
| Q34776698 | Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. |
| Q36375559 | Pittsburgh compound B and the postmortem diagnosis of Alzheimer disease. |
| Q36713678 | Postmortem Pittsburgh Compound B (PiB) binding increases with Alzheimer's disease progression. |
| Q35633470 | Preclinical AD Workgroup staging: pathological correlates and potential challenges. |
| Q35963453 | Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognition |
| Q55716450 | Preventing P-gp Ubiquitination Lowers Aβ Brain Levels in an Alzheimer's Disease Mouse Model. |
| Q34445021 | Primary age-related tauopathy (PART): a common pathology associated with human aging |
| Q33937968 | Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease |
| Q34493905 | Proteolysis of calcineurin is increased in human hippocampus during mild cognitive impairment and is stimulated by oligomeric Abeta in primary cell culture |
| Q53396498 | Psychosis in "Cognitively Asymptomatic" Elderly Subjects is Associated With Neuritic Plaque Load, Not Neurofibrillary Tangles. |
| Q58114831 | Qualitative Comparison of Semantic Memory Impairment in Patients with Amnestic Mild Cognitive Impairment Based on β-Amyloid Status |
| Q37246539 | Quantitation and mapping of cerebral detergent-insoluble proteins in the elderly |
| Q34584768 | Quantitative neuropathological assessment to investigate cerebral multi-morbidity. |
| Q33556068 | Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment |
| Q90732288 | Regional times to equilibria and their impact on semi-quantification of [18F]AV-1451 uptake |
| Q37739881 | Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition |
| Q37393410 | Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies |
| Q92591355 | Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort |
| Q40135861 | Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals |
| Q39065455 | Risk of incident clinical diagnosis of Alzheimer's disease-type dementia attributable to pathology-confirmed vascular disease |
| Q34764490 | Role of the neuropathology of Alzheimer disease in dementia in the oldest-old |
| Q36729304 | Self-Reported Memory Complaints: A Comparison of Demented and Unimpaired Outcomes |
| Q28387899 | Self-reported head injury and risk of late-life impairment and AD pathology in an AD center cohort |
| Q34303840 | Self-reported memory complaints: implications from a longitudinal cohort with autopsies |
| Q47864065 | Single-Base Resolution Mapping of 5-Hydroxymethylcytosine Modifications in Hippocampus of Alzheimer's Disease Subjects. |
| Q37410164 | Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline. |
| Q33556006 | Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions |
| Q34993414 | Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease |
| Q46034389 | Synthesis and preliminary evaluation of 2-arylhydroxyquinoline derivatives for tau imaging. |
| Q57178723 | Tau-targeting therapies for Alzheimer disease |
| Q26999358 | The 5-lipoxygenase pathway: oxidative and inflammatory contributions to the Alzheimer's disease phenotype |
| Q46251905 | The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases |
| Q37305212 | The Effect of Vascular Neuropathology on Late-life Cognition: Results from the SMART Project |
| Q94376626 | The Statistical Modeling of Aging and Risk of Transition Project: Data Collection and Harmonization Across 11 Longitudinal Cohort Studies of Aging, Cognition, and Dementia |
| Q33722837 | The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. |
| Q53397866 | The human MAPT locus generates circular RNAs. |
| Q33786327 | The neuropathology of older persons with and without dementia from community versus clinic cohorts |
| Q33616561 | The neuropathology of probable Alzheimer disease and mild cognitive impairment |
| Q34484708 | The overlap between vascular disease and Alzheimer's disease--lessons from pathology |
| Q36731049 | The role of cerebrovascular disease when there is concomitant Alzheimer disease |
| Q28554402 | Three Dimensional Human Neuro-Spheroid Model of Alzheimer's Disease Based on Differentiated Induced Pluripotent Stem Cells |
| Q92267911 | Tobacco Smoking and Dementia in a Kentucky Cohort: A Competing Risk Analysis |
| Q36131008 | University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology |
| Q34418781 | Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models |
| Q87927295 | What can we learn about brain donors? Use of clinical information in human postmortem brain research |
| Q35215656 | What we can learn from animal models about cerebral multi-morbidity |
| Q39752120 | White Matter Changes in Bipolar Disorder, Alzheimer Disease, and Mild Cognitive Impairment: New Insights from DTI. |
| Q86424124 | [Pathogenesis and prevention of Alzheimer's disease: when and in what way does the pathological process begin?] |
Search more.